InflaRx develops new therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application.

Type
Public
HQ
Jena, DE
Founded
2006
Size (employees)
9 (est)
InflaRx was founded in 2006 and is headquartered in Jena, DE
Report incorrect company information

InflaRx Office Locations

InflaRx has offices in Planegg and Jena
Planegg, DE
5 Semmelweisstraße
Show all (2)
Report incorrect company information

InflaRx Financials and Metrics

InflaRx Revenue

InflaRx's revenue was reported to be €108 k in FY, 2017 which is a 53.2% decrease from the previous period.
EUR

Revenue (FY, 2017)

108 k

Revenue growth (FY, 2016 - FY, 2017), %

(53.2%)

Net income (FY, 2017)

(24.2 m)

EBIT (FY, 2017)

(19.4 m)

Market capitalization (18-Jul-2018)

898.2 m

Closing share price (18-Jul-2018)

35

Cash (31-Dec-2017)

123.3 m
InflaRx's current market capitalization is $898.2 m.
EURFY, 2015FY, 2016FY, 2017

Revenue

134 k231 k108 k

Revenue growth, %

72%(53%)

General and administrative expense

438 k1.8 m5.1 m

R&D expense

3.5 m5.3 m14.4 m
EURFY, 2015FY, 2016FY, 2017

Cash

3.3 m29.1 m123.3 m

Current Assets

3.5 m29.4 m124 m

PP&E

109 k131 k173 k

Total Assets

3.6 m29.5 m124.2 m
EURFY, 2015FY, 2016FY, 2017

Net Income

(4.9 m)(8.9 m)(24.2 m)

Depreciation and Amortization

40 k33 k71 k

Cash From Operating Activities

(3.3 m)(5 m)(12.2 m)

Cash From Investing Activities

(13 k)(53 k)(167 k)
EURY, 2017

Revenue/Employee

12 k

Financial Leverage

1 x

P/E Ratio

(13.5 )
Show all financial metrics
Report incorrect company information

InflaRx News and Updates

Report incorrect company information

InflaRx Company Life and Culture

Report incorrect company information